Tumor-driven SRS VMAT planning: Regression models for intermediate and low dose spillage
Meysam Tavakoli1, Shada Wadi-Ramahi2, Sarah Ashmeg2
1Department of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
Journal of Applied Clinical Medical Physics
|July 31, 2025
Summary
This study developed regression models to predict radiation dose in stereotactic radiosurgery (SRS) for brain metastases. These models use tumor characteristics to standardize planning and improve treatment consistency.
Area of Science:
- Radiation Oncology
- Medical Physics
- Neurosurgery
Background:
- Stereotactic radiosurgery (SRS) using volumetric modulated arc therapy (VMAT) is increasingly used for brain metastases.
- Existing guidelines for high-dose conformity in SRS are insufficient for intermediate and low-dose regions.
- Standardization of intracranial SRS planning requires better understanding of dose distribution.
Purpose of the Study:
- To develop regression models for standardizing intracranial SRS planning.
- To explore tumor-specific characteristics and novel dosimetric parameters for predicting dose distribution.
- To provide patient-specific guidance for optimizing SRS plan quality.
Main Methods:
- Retrospective analysis of 290 VMAT SRS plans from 151 patients.
- Introduction of new dosimetric quantities: R6Gy (6 Gy cloud volume ratio) and %D1cm (max dose at 1 cm).
- Evaluation of R50%, V12Gy, number of metastases (n), and total planning target volume (PTVTotal) using correlation and regression analyses.
Main Results:
- Strong correlations between PTVTotal and dosimetric metrics in single-fraction SRS; weaker correlations in three-fraction SRS.
- Power-law regression models best described R50% and R6Gy.
- Linear regression models best described %D1cm and V12Gy; moderate correlations found between n and dosimetric metrics.
Conclusions:
- Proposed regression-based models predict radiation dose spill based on tumor burden and volume.
- These models offer a framework for model-based SRS planning.
- The findings aim to improve consistency, optimize plan quality, and support standardization in SRS treatment planning.


